Appropriate ME Treatment Debate
Full Debate: Read Full DebateKevin Foster
Main Page: Kevin Foster (Conservative - Torbay)Department Debates - View all Kevin Foster's debates with the Department of Health and Social Care
(5 years, 7 months ago)
Commons ChamberIt is a pleasure to be called to speak in this debate, and particularly to follow the hon. Member for South Shields (Mrs Lewell-Buck) and her comments. I thank the constituents who contacted me ahead of the debate not only to encourage me to attend but to make clear their concerns about this issue. Several Members have picked up a point on which I shall reflect as well: ME can have such an impact on someone’s life, but at the same time they sometimes have to battle for recognition that that is what is affecting them. Of course, there is no specific test for the condition, which leads on to the fact that there is no specific cure for it. As we heard in the previous speech, that can lead to scepticism rather than someone being supported.
As several Members have already said, this condition has a £3.3 billion impact per year, in terms of healthcare costs, the related welfare payments, productivity losses and unpaid informal care, as well as, of course, the wider lost opportunity because those who suffer from this condition are not able to live life to the full or as they would wish. It will be interesting to hear from the Minister about the review of the NICE guidelines. For the reasons that other Members have already gone into, it is welcome that we know what is being looked at, but it would be particularly welcome to hear whether we might be able to bring forward some updated guidelines earlier than the stated timeline of 2020. It would be interesting to hear the Minister say that when he responds to the debate.
As has also been touched on already, when one considers the impact of ME, it is quite remarkable to see how little is spent on research. I think something like only 0.02% of all active grants given by UK mainstream funding agencies goes towards research in this area. Clearly, without research, there will not be the hope of improved treatment or of a test being developed so that people can move away from scepticism and get support from their medical practitioners. Ultimately, we will hopefully find a cure, or a treatment that at least mitigates some of ME’s effects.
Members have already touched on the fact that there is clearly an issue in relation to how those living with this condition are assessed for welfare benefits, particularly because they might be assessed on a good day, which does not then reflect their overall condition. When he sums up, it would be interesting to hear the Minister reflect on some of the conversations that the Department of Health and Social Care is having with the Department for Work and Pensions, although I accept that he is unlikely to get a particularly long time to sum up, given the short length of the debate.
I welcome the opportunity today to highlight this issue on the Floor of the House, and I congratulate the hon. Member for Glasgow North West (Carol Monaghan) and the other Members who applied on securing this debate and enabling us to raise our concerns on a cross-party basis. As has been touched on, 250,000 people live with this condition in the UK. It needs research, support and a change of culture, so that sufferers feel supported and believed and can have some hope of living the sort of normal life that we all expect and deserve.